Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2002-03-25
2009-10-13
Kim, Jennifer Myong M (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S255030, C514S392000, C514S343000
Reexamination Certificate
active
07601720
ABSTRACT:
This invention relates to the use of nicotine receptor agonists for treating inflammatory diseases, including a variety of pulmonary diseases. Such agonists have fewer side effects than other anti-inflammatory drugs, such as steroids. Moreover, these agonists can be used alone or in combination with other anti-inflammatory drugs to alleviate pulmonary diseases.
REFERENCES:
patent: 2778772 (1957-01-01), Chen
patent: 3402039 (1968-09-01), Mussell et al.
patent: 5846983 (1998-12-01), Sandborn et al.
patent: 5977144 (1999-11-01), Meyer et al.
patent: 5981549 (1999-11-01), Viner
patent: 6177429 (2001-01-01), Sit et al.
patent: 6610713 (2003-08-01), Tracey
patent: 6838471 (2005-01-01), Tracey
patent: 2002/0151597 (2002-10-01), Banerjee et al.
patent: 2002/0160988 (2002-10-01), Amitai et al.
patent: 2004/0116519 (2004-06-01), Slatter
patent: 2004/0132737 (2004-07-01), Cormier et al.
patent: 2004/0132774 (2004-07-01), Heath
patent: 2004/0138289 (2004-07-01), Richards et al.
patent: 2004/0242569 (2004-12-01), Lennon et al.
patent: 2004/0254373 (2004-12-01), Piotrowski et al.
patent: 2005/0019271 (2005-01-01), Bannister et al.
patent: 2005/0075323 (2005-04-01), Day et al.
patent: 2005/0130990 (2005-06-01), Cormier et al.
patent: 1462091 (2004-09-01), None
patent: 2003/176240 (2003-06-01), None
patent: WO96/15117 (1996-05-01), None
patent: WO 98 02188 (1998-01-01), None
patent: WO/99/21834 (1999-05-01), None
patent: WO 00 23062 (2000-07-01), None
patent: WO 01 15697 (2001-03-01), None
patent: WO 02 44176 (2002-06-01), None
patent: WO/2002/076434 (2002-10-01), None
patent: WO/2006/005195 (2006-01-01), None
Migueres et al. Techniques of Desensitiazation. Revue des Maladies Respiratories, 1986 vol. 3, No. 1 pp. 39-44, abstract.
Ikemori et al. Doctor-patient relationship in the treatment of bronchial ashtma. Japanese Journal of Psychosomatic Medicine, 1979 vol. 19, No. 5, pp. 359-364. (abstract).
The Merck Manual, 16thEdition, pp. 658-659.
Cormier, Y. et al. 1985,Factors influencing the development of serum precipitins to farmer's lung antigen in Quebec dairy farmers, Thorax 40(2): 138-142.
Cormier, Y. et al., 1988,Sequential bronchoalveolar lavage in experimental extrinsic allergic alveolitis. The influence of cigarette smoking, Am Rev Respir Dis 137(5): 1104-1109.
Cormier, Y. et al., 1998,Hypersensitivity pneumonitis in peat moss processing plant workers, Am J Respir. Crit Care Med 158(2): 412-417.
Gariepy, L. et al., 1989,Predictive value of bronchoalveolar lavage cells and serum precipitins in asymptomatic dairy farmers, Am Rev Respir Dis. 140(5): 1386-1389.
Lawrence, E.C. et al., 1986,Cigarette smoking and bronchoalveolar T Cell populations in sarcoidosis, Ann N Y Acad Sci 465:657-664.
Valeyre D. et al., 1988,Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease, Thorax 43(7):516-524.
Rubin, D.T. and Hanuer, S. B., 2000,Smoking and inflammatory bowel disease. Eur J Gastroenterol Hepetol 12(8):855-862.
Thomas, G.A. et al., 2000,Role of smoking in flammatory bowel disease : implications for therapy. Postgrad Med J 76(895):273-279.
Guslandi, M., 1999,Nicotine Treatment for ulcerative colitis. Br . Clin Pharmacol48(4):481-484.
Guslandi, M., 1999,Long-term effects of a single course of nicotine treatment in acute ulcerative colitis:remission maintenance in a 12-month follow-up study. Int J Colorectal Dis 14(4-5):261-262.
Rezvani, A.H. and Levin E.D., 2001,Cognitive effects of nicotine. Biol Psychiatry 49(3):258-267.
Kelton, M.C. et al., 2000,The effects of nicotine in Parkinson's disease. Brain Cogn 43(1-3):274-282.
Bertram, K.G., 1998,Basic and clinical pharmacology. Editions Appelton and Lange. Stanford. Connecticut.
Sekhon, H.S. et al., 1999,Prenatal nicotine increases pulmonary alpha 7 nicotinic receptor expression and alters feta lung development in monkeys. J Clin Invesst 103(5):637-647.
Maus, A.D. et al., 1998,Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors, Mol Pharmacol 54(5):779-788.
Shriver, S.P. et al., 2000,Sex-specific expression of gastrin-releasing peptide receptor : relationship to smoking history and risk of lung cancer. J Natl Cancer Inst. 92(1).
Ferguson, D.G. et al., 2000,The alpha3 subtype of the nicotinic acetylcholine receptor is expressed in airway-related neurons of the nucleus tractus solitarius, but is not essential for reflex bronchoconstriction in ferrets. Neurosci Lett 287(2):141-145.
Singh, S.P. et al., 2000,Acute and chronic nicotine exposures modulate the immune system through different pathways. Toxicol Appl Pharmacol 164(1): 65-72.
Kalra, R. et al., 2000,Effects of cigarette smoke on immune response:chronic exposure to cigarette smoke impairs antigen-mediated signaling in T cells and depletes IP3-sensitive Ca(2+)stores. J Pharmacol Exp Ther 293(1):166-171.
Sugano, N. et al., 1998,Nicotine inhibits the production of inflammatory mediators in U937 cells through modulation of nuclear factor-kappaB activation,. Biochem Biophys Res Commun 252(1):25-28.
Yates, S.L. et al., 1995,Up-regulation of nicotinic acetycholine receptors following chronic exposure of rats to mainstream cigarette smoke or alpha 4 beta 2 receptors to nicotine. Biochem Pharmacol 50(12):2001-2008.
Sopori, M.L. and Kosak W., 1998,Immunomodulatory effects of cigarette smoke. J Neuroimmunol 83(1-2):148-156.
Lahmouzi, J. et al., 2000,Effect of nicotine on rat gingival fibroblasts in vitro. Connect Tissue Res 41(1):69-80.
Geng, Y. et al., 1996,Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy, J Immunol 156(7):2384-2390.
McCrea, K.A. et al., 1994,Altered cytokine regulation in the lungs of cigarette smokers, Am J Respir Crit Care Med 150(3):696-703.
Ohta, T. et al., 1998,Cigarette smoking decreases interleukin-8 secretion by human alveolar macrophages, Respir. Med. 92(7):922-7.
Suzuki, N. et al., 1999,Effects of cigarette smoking on Fas/Fas ligand expression of human lympocytes. Cell Immunol 192(1):48-53.
Zia, S. et al., 1997,Nicotine enhances expression of the alpha 3, alpha 4, alpha 5, and alpha 7 nicotinic receptors modulating calcium metabolism and regulating adhesion and motility of respiratory epithelial cells,. Res Commun Mol Pathol Pharmacol 97(3):243-262.
Zhang, S. and Petro T.M.., 1996,The effects of nicotine on murine CD4 T cell responses. Int J Immunopharmacol18(8-9):467-478.
Bugeon, L and Dallman J., 2000,Constimulation of T cells. Am J Respir Crit Care Med 162(4 Pt 2): S164-168.
Green, J.M., 2000,The B7/CD28/CTLA4 T-cell activation pathway. Implications for inflammatory lung disease. Am. J. Respir. Cell. Mol. Biol. 22(3):261-264.
Lenschow, D.J. et al., 1996CD28/B7 system of T cell costimulation. Annu Rev. Immunol. 14:233-258.
Walunas, T.L. and Bluestone J.A., 1998,CTLA-4 regulates tolerance induction and T cell differentiation in vivo. J Immunol 160(8):3855-3860.
Walunas, T.L. et al., 1994,CTLA-4 can function as a negative regulator of T cell activation. Immunity 1(5):405-413.
Israel-Assayag, E. et al., 1999,Expression of costimulatory molecules on alveolar macrophages in hypersensitivity pneumonitis, Am J Respir Crit Care Med 159(6): 1830-1834.
Israel-Assayag E. et al., 1999,Blockade of T cell constimulation by CTLA4-lg inhibits lung inflammation in murine hypersensitivity pneumonitis, J Immunol 163(12): 6794-6799.
Larche, M. et al., 1998,Costimulation throuth CD86 is involved in airwat antigen-presenting cell and T cell responses to allergen in atopic asthmatics, J Immunol 161(11):6375-6382.
Mathur, M. et al., 1999,CD28 interactions with either CD80 or CD86 are sufficient to induce allergic airway inflammation in mice. Am J Respir Cell Mol Biol 21(4):498-509.
Nicod, L.P. and Isler, P., 1997,Alveolar macrophages in sarcoidosis coexpress high levels of CD86(B7.2), CD40, and CD30L. Am J Respir Cell Mol Biol 17(1):91-6.
Kesingland, A.C. et al., 2000,Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropahtic pain, P
Blanchet Marie-Renée
Cormier Yvon
Israel-Assayag Evelyne
Buchanan & Ingersoll & Rooney PC
Kim Jennifer Myong M
Universite Laval
LandOfFree
Nicotinic receptor agonists for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nicotinic receptor agonists for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nicotinic receptor agonists for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4082049